AMOEBA (EPA:ALMIB) | WebDisclosure

Basculer en Français

11276	Companies
250579	Keywords
179215	Articles
136418	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 10/09/2025 at 18:00, 1 year ago

Amoéba: a first half of 2025 marked by numerous decisive achievements ahead of the commercial launch of its biocontrol solution in 2026
Amoéba achieved crucial milestones for the commercialisation of AXPERA and the development of its cosmetics segment, strengthening its financial structure with a successful capital increase

AMOEBA Financial Structure Biocontrol Cosmetics AXPERA
PRESS RELEASE

published on 10/09/2025 at 18:00, 1 year ago

Amoéba : un 1er semestre 2025 marqué par de nombreuses avancées déterminantes avant le lancement commercial de sa solution de biocontrôle en 2026
Amoéba franchit des étapes clés: approbation pour AXPERA, accord avec Koppert, avancée en cosmétique et renforcement financier. Résultats semestriels en progression

Résultats Financiers AMOEBA Biocontrôle Cosmétique AXPERA
BRIEF

published on 10/02/2025 at 08:05, 1 year 1 month ago

Amoéba progresse vers la mise sur le marché d'Axpera en 2026

AMOEBA Viticulture 2026 AXPERA Homologations
BRIEF

published on 10/02/2025 at 08:05, 1 year 1 month ago

Amoéba progresses towards the commercialization of Axpera in 2026

AMOEBA Viticulture 2026 AXPERA Approvals
PRESS RELEASE

published on 10/02/2025 at 08:00, 1 year 1 month ago

Amoéba accelerates the development of Axpera: Very convincing results observed by winegrowers; An approval schedule in line with the market launch in 2026.
Amoéba to present positive results of wine-growing trials with its innovative biological solution 'AXPERA' to agricultural press, amidst changing plant health regulations in France and Europe

AMOEBA AXPERA Wine-growing Trials Biological Solution Plant Health Regulations
PRESS RELEASE

published on 10/02/2025 at 08:00, 1 year 1 month ago

Amoéba accélère le développement d'Axpera : Des résultats très convaincants constatés par les viticulteurs ; Un calendrier des homologations en ligne avec la mise sur le marché en 2026.
Amoéba annonce des résultats positifs de sa campagne d'essais viticoles en France et Europe avec sa solution biologique innovante. Homologations en cours pour une mise sur le marché en 2026

AMOEBA Biocontrôle AXPERA Homologations Essais Viticoles
BRIEF

published on 09/08/2025 at 08:05, 1 year 1 month ago

Edison fixe un objectif de cours à 2,01 EUR pour Amoéba

AMOEBA Objectif De Cours GreenTech Edison Group Solutions Naturelles
BRIEF

published on 09/08/2025 at 08:05, 1 year 1 month ago

Edison sets a price target of EUR 2.01 for Amoéba

AMOEBA Course Objective Natural Solutions GreenTech Edison Group
PRESS RELEASE

published on 09/08/2025 at 08:00, 1 year 1 month ago

Amoéba : Edison fixe un objectif de cours à 2,01 EUR
Amoéba, greentech spécialisée en solutions microbiologiques naturelles, reçoit une étude d'Edison Group soulignant un potentiel d'appréciation de plus de 100% et mettant en avant sa croissance future

AMOEBA GreenTech Étude Edison Group Microbiologique
PRESS RELEASE

published on 09/08/2025 at 08:00, 1 year 1 month ago

Amoéba: Edison sets a target price of EUR 2.01
Amoéba, the greentech company specializing in natural microbiological solutions, receives positive analysis from Edison Group praising future growth potential backed by distribution partnerships and demand for natural products

AMOEBA Financial Analysis GreenTech Edison Group Microbiological Solutions

Accesswire

Published on 11/04/2026 at 23:10, 1 hour 49 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 1 hour 59 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 1 hour 59 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 2 hours 44 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 2 hours 54 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 00:02, 56 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 5 hours 17 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 5 hours 33 minutes ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 6 hours 16 minutes ago

EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 6 hours 53 minutes ago

Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production

Les Echos

Published on 11/04/2026 at 18:00, 6 hours 58 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 6 hours 58 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 7 hours 14 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 7 hours 14 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 7 hours 15 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE